Pet image skull-thigh
CPT code 78812 covers a PET (Positron Emission Tomography) scan that images from the skull down to the thigh, used to detect cancer, assess treatment response, or identify areas of abnormal metabolic activity in the upper body and torso.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Verify exact anatomical coverage documented matches skull-to-thigh boundaries; if imaging extends to full body, use 78813 instead to avoid underbilling
Impact: Using wrong PET code can result in $100+ reimbursement differences; 78813 typically reimburses 15-20% higher
Confirm medical necessity documentation includes specific cancer diagnosis or clinical indication; payers deny PET scans without oncologic justification
Impact: Prevents 100% denial ($85.72 lost revenue per claim); prior authorization approval rates increase from 60% to 95% with proper documentation
Bill with appropriate modifier 26 if only interpreting images acquired at different facility; never bill global code without owning technical component
Impact: Incorrect global billing triggers recoupment of full payment minus professional component, typically $40-50 per claim
Document time interval from previous PET scan and clinical justification for repeat imaging; Medicare LCD policies restrict frequency
Impact: Scans performed within restricted timeframes face 70-80% denial rate unless exception criteria documented
Link to specific ICD-10 codes for known malignancy (C codes) rather than screening or symptoms; PET is not a screening tool for asymptomatic patients
Impact: Proper diagnosis coding increases first-pass acceptance rate by 35%; screening indications result in automatic denials
Ensure radiopharmaceutical administration is billed separately with appropriate A-codes (A9552 for FDG) by technical component provider
Impact: Radiopharmaceutical represents $800-1200 in additional reimbursement; must be billed by facility/technical provider, not interpreting physician
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.